Abstract
753P - Prognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have